Second-generation DES vs first-generation DES in diabetic patients with coronary artery disease

被引：0
|
作者：
Kufner, S. [1 ]
Byrne, R. [1 ]
Mehilli, J. [1 ]
Dommasch, M. [1 ]
Massberg, S. [1 ]
Schoemig, A. [1 ]
Kastrati, A. [1 ]
机构：
[1] Deutsch Herzzentrum Munich, Munich, Germany
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：386 / 387
页数：2
相关论文
共 50 条
  • [31] Clinical Impact of Second-Generation Everolimus-Eluting Stents Compared With First-Generation Drug-Eluting Stents in Diabetic Patients Undergoing Multivessel Percutaneous Coronary Intervention
    Pendyala, Lakshmana
    Loh, Joshua
    Kitabata, Hironori
    Minha, Sa'ar
    Chen, Fang
    Torguson, Rebecca
    Suddath, William
    Satler, Lowell
    Pichard, Augusto
    Waksman, Ron
    JOURNAL OF INVASIVE CARDIOLOGY, 2015, 27 (06): : 263 - 268
  • [32] CLINICAL IMPACT OF SECOND-GENERATION EVEROLIMUS-ELUTING STENTS COMPARED WITH FIRST-GENERATION DRUG-ELUTING STENTS IN DIABETIC PATIENTS UNDERGOING MULTIVESSEL PERCUTANEOUS CORONARY INTERVENTION
    Pendyala, Lakshmana
    Loh, Joshua
    Torguson, Rebecca
    Satler, Lowell
    Minha, Sa'ar
    Baker, Nevin
    Alarcon, Ricardo Escarcega
    Ota, Hideaki
    Pichard, Augusto
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1909 - A1909
  • [33] Biodegradable-polymer DES versus second-generation durable-polymer DES
    Bryony M. Mearns
    Nature Reviews Cardiology, 2014, 11 (1) : 6 - 6
  • [34] Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in bipolar disorder patients unexposed to first-generation antipsychotic
    Cho, Y.
    Lee, A.
    Kim, J.
    Kim, J.
    Choi, M.
    Yoon, S.
    Ha, K.
    Hong, K.
    BIPOLAR DISORDERS, 2015, 17 : 87 - 88
  • [35] Second-Generation Everolimus-Eluting Stents Compared to First-Generation Drug-Eluting Stents in Patients Treated for Multivessel Disease
    Minha, Sa'ar
    Barbash, Israel M.
    Dvir, Danny
    Loh, Joshua P.
    Badr, Salem
    Kitabata, Hironori
    Pendyala, Lakshmana K.
    Pichard, Augusto D.
    Torguson, Rebecca
    Waksman, Ron
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2013, 26 (06) : 561 - 569
  • [36] Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
    Ansell, B. R. E.
    Dwyer, D. B.
    Wood, S. J.
    Bora, E.
    Brewer, W. J.
    Proffitt, T. M.
    Velakoulis, D.
    McGorry, P. D.
    Pantelis, C.
    PSYCHOLOGICAL MEDICINE, 2015, 45 (03) : 515 - 527
  • [37] 10-year clinical outcomes after bare-metal, first-generation and second-generation drug-eluting stent implantation for left main coronary artery disease in patients with acute coronary syndrome
    Ko, E. K.
    Toyofuku, T. M.
    Tamura, T. T.
    Morimoto, T. M.
    Kimura, T. K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1181 - 1182
  • [38] SECOND-GENERATION EVEROLIMUS-ELUTING STENTS VERSUS FIRST-GENERATION DRUG-ELUTING STENTS FOR PATIENTS TREATED FOR MULTIVESSEL DISEASE
    Minha, Sa'ar
    Barbash, Israel
    Dvir, Danny
    Ben-Dor, Itsik
    Loh, Joshua
    Badr, Salem
    Pendyala, Lakshmana
    Kitabata, Hironori
    Satler, Lowell
    Pichard, Augusto
    Suddath, William
    Kent, Kenneth
    Torguson, Rebecca
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1705 - E1705
  • [39] Clinical Efficacy and Safety of the Second-Generation Everolimus-Eluting Stents Compared top the First-Generation Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease: Insights From Randomized Trials
    Zhang, Feng
    Qian, Juying
    Ge, Junbo
    CIRCULATION, 2010, 122 (21)
  • [40] First-generation vs second-generation tyrosine kinase inhibitors: which is best at diagnosis of chronic phase chronic myeloid leukemia?
    Oehler, Vivian G.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 228 - 236
12345